Aptuit beefs up API biz; GVK scandal cast shadow in India;

> Contract manufacturer Aptuit is expanding its API operation in in the U.K. and Italy in response to a surge in demand. Item

> The data manipulation scandal at GVK Biosciences has unduly marred the reputation of Indian clinical trials, an industry group tells Outsourcing-Pharma. More

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.